Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2024 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies, Inc. Files Form 10 with the Securities and Exchange Commission and Submits Nasdaq Application for Uplisting

BioStem Technologies, Inc. Files Form 10 with the Securities and Exchange Commission and Submits Nasdaq Application for Uplisting
August 29, 2024 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET

BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
August 21, 2024 07:00 ET | Source: Biostem Technologies

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje®
August 12, 2024 16:14 ET | Source: Biostem Technologies

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
August 05, 2024 08:00 ET | Source: Biostem Technologies

BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024

BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
July 10, 2024 07:15 ET | Source: Biostem Technologies

BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers

BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
June 26, 2024 08:30 ET | Source: Biostem Technologies

BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study

BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
May 29, 2024 11:00 ET | Source: Biostem Technologies

BioStem Technologies to Sponsor MRO Better Half Dash

BioStem Technologies to Sponsor MRO Better Half Dash
May 14, 2024 16:01 ET | Source: Biostem Technologies

BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million

BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
May 07, 2024 08:00 ET | Source: Biostem Technologies

BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right